BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Policy

  Cardiovascular Systems Ducks a Class-Action Kickbacks Suit

  April 3, 2017

   · 

  1 min read
• 

  Mylan Expands EpiPen Recall To The U.S.

  April 3, 2017

   · 

  7 min read
• 

  BioCapital

  3 Biotechs Wall Street Predicts is Heading Toward Tremendous Growth

  April 3, 2017

   · 

  3 min read
• Pharm Country

  For Bristol-Myers Squibb Cancer Drug, A Victory—And A Mystery

  April 3, 2017

   · 

  1 min read
• 

  Business

  Sucampo Pays $200 Million Upfront for Rare Disease Biotech Vtesse

  April 3, 2017

   · 

  3 min read
• 

  Drug Development

  4 Drug Stocks With Major FDA Decisions Coming This Month

  April 3, 2017

   · 

  2 min read
• 

  Deals

  Astellas Takes Out Belgium Biotech in Deal Worth $853 Million

  April 3, 2017

   · 

  2 min read
• 

  Deals

  Bristol-Myers Squibb Who? Why Pfizer Could be Making Googly Eyes at This Michigan Biotech Instead

  April 3, 2017

   · 

  3 min read
• Business

  To Infinity And Beyond: Julian Adams On Missteps And His New Job

  April 3, 2017

   · 

  1 min read
• 

  Drug Development

  This Little-Known $12 Billion SoCal Startup Wants to Cure Baldness and Smooth Out Your Wrinkles

  April 3, 2017

   · 

  2 min read